NASDAQ / LIVE COMPANY INTELLIGENCE

Traws Pharma, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERTRAW
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / TRAW COVERAGE

What’s moving Traws Pharma, Inc. now

Current reporting with the operating signal separated from the noise.

01
Traws Pharma, Inc.: Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program

Traws Pharma, Inc.: Traws Pharma Provides Updated Guidance on Influenza Prophylaxis Program

The story matters when it changes Traws Pharma, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Traws Pharma, Inc. (NASDAQ:TRAW) Q4 2025 Earnings Call Transcript

Traws Pharma, Inc. (NASDAQ:TRAW) Q4 2025 Earnings Call Transcript

Investors are testing whether Traws Pharma, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Traws Pharma, Inc. (NASDAQ:TRAW) Q2 2025 Earnings Call Transcript

Traws Pharma, Inc. (NASDAQ:TRAW) Q2 2025 Earnings Call Transcript

Investors are testing whether Traws Pharma, Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Traws Pharma, Inc. Reports Positive Topline Results from Ferret Studies on Tivoxavir Marboxil for H5N1 Bird Flu Treatment

Traws Pharma, Inc. Reports Positive Topline Results from Ferret Studies on Tivoxavir Marboxil for H5N1 Bird Flu Treatment

The story matters when it changes Traws Pharma, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
05
Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors

Traws Pharma, Inc. Appoints Luba Greenwood to Board of Directors

The story matters when it changes Traws Pharma, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
06
Traws Pharma, Inc. (TRAW) Corporate Update Call Transcript

Traws Pharma, Inc. (TRAW) Corporate Update Call Transcript

The story matters when it changes Traws Pharma, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest TRAW filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-15 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-13 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-04-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-31 · Period 2026-07-29SEC ↗8-KMaterial company eventFiled 2026-07-10 · Period 2026-07-10SEC ↗8-KMaterial company eventFiled 2026-07-09 · Period 2026-07-08SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-05-29 · Period 2026-07-08SEC ↗4Official SEC filingFiled 2026-07-16 · Period 2026-07-09SEC ↗
EARNINGS / QUARTERLY TRACKER

Traws Pharma, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.